FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to novel triterpene derivatives of formulaand formulaactive with respect to HIV, as well as HIV-mediated diseases, and to an intermediate compound of formulaIn the general formula (I) R stands for H, substituted or non-substituted C1-6 alkyl, benzyl or substituted or non-substituted C4-5 cycloalkyl and preferably R is substituted with Ra； R' stands for H, substituted or non-substituted C1-6 alkyl, substituted or non-substituted C4-5 cycloalkyl, substituted or non-substituted C4-5 cycloalkenyl,substituted piperazinyl, substituted piperidinyl, substituted 8-azabicyclo[3.2.1]octane, 4-ethyl-2,2,6-trimethyl-1.3-dioxane, hexane-2,4-diol or (S)-1-((4aS,8aS)-octahydroisoquinolin-2(1H)-yl)-4-phenylbutan-2-ol and preferably R′ can be substituted with Ra； X is selected from a bond and -C(O)-； X1 is selected from -C(O)-, -C(O)2- or -C(O)NR"-； Z stands for -O-； Z1 stands for a bond； Z' stands for H； n equals 0； m equals 1,″″ stands for a single bond； R1 stands for H； R2 stands for -C(=CH2)(CH3)； Ra stands for cyano, phenyl, benzyl, ethyl, 3-isopropyl-5-methyl-1,2,4-triazole, -C(O)2R", -C(O)R", -CH2OR", -C(O)N(R)"2 or substituted or non-substituted C1-6 alkyl, where the substituent is selected from -OH, morpholinyl, benzyl, -COOMe, piperazinyl, optionally substituted with ethyl, piperidinyl, optionally substituted with methyl, -COOH, or benzyl； and each R" is independently selected from H, substituted or non-substituted C1-6 alkyl, methyl 3-methylbutanoate, 3-methylbutanic acid, 4-methylpentanic acid, methyl 4-methylpentanoate, methyl propionate, propanoic acid, 1-morpholinopropan-1-one, 1-(pyrrolidin-1-yl)propan-1-one, 4-ethylpiperazinyl, morpholinyl, piperidinyl, optionally substituted with -COOEt, pyrrolidinyl or benzyl. In formula (2A) XA1 stands for a bond or -C(O)-； XA2 stands for a bond, O or NH； RA1 stands forRb stands for substituted or non-substituted C1-6 alkyl； RA2 stands for substituted or non-substituted a
